Antidepressant response and intolerance to SSRI is not influenced by G-protein beta 3 subunit gene C825T polymorphism in Japanese major depressive patients

作者：Kato Masaki^*; Wakeno Masataka; Okugawa Gaka; Fukada Tsuyoshi; Takekita Yoshiteru; Hosoi Yuka; Azuma Junichi; Kinoshita Toshihiko; Serretti Alessandro

来源：Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008, 32(4): 1041-1044.

DOI：10.1016/j.pnpbp.2008.01.019

• depression
• G-protein beta 3
• pharmacogenetics
• side effects
• treatment response

The G-protein beta 3 subunit (GNB3) gene is a key modulator of signal transduction and is a major candidate for SSRIs response. The aim of the present study is to test a possible effect of the C825T polymorphism on the antidepressant response and intolerance to selective scrotonin reuptake inhibitors (SSRIs) in 146 Japanese samples with major depression treated with paroxetine or fluvoxamine for 6 weeks. The severity of depression symptom was assessed using the 21-item Hamilton Rating Scale for Depression (HAM-D) and adverse drug reactions were evaluated bi-weekly. No association with SSRIs treatment response was observed in 107 completers also including HAM-D baseline scores, SSRI type or/and 5-HTTLPR variants in the model as covariates. Furthermore, no significant association could be observed with intolerance to SSRIs in the whole subjects. The result suggests that C825T variants of GNB3 cannot play a major role as a predictor of treatment response as well as intolerance to SSRIs in Japanese patients with major depression.

• 出版日期2008-5-15